PAMELA CHUMPITAZ: Open Payments
NPI 1528424173 · EL MONTE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$266 in 11 payments from 5 companies in 2025. Trend: 2023 $46 · 2024 $29 · 2025 $266
Food & beverage: $266
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $115 |
| Luye Pharma (USA) Ltd. | 2 | $54 |
| Alkermes, Inc. | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 1 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
Products named: UZEDY, ERZOFRI EXTENDED-RELEASE, ARISTADA, COBENFY, CAPLYTA.
Industry payments across CA — which companies pay providers there.
